ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 281 filers reported holding ROYALTY PHARMA PLC in Q2 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $138,043,504 | -8.8% | 3,831,349 | +0.0% | 0.04% | -12.2% |
| Q4 2022 | $151,407,443 | -24.6% | 3,831,160 | -23.4% | 0.04% | -30.5% |
| Q3 2022 | $200,833,000 | -4.4% | 4,998,342 | +0.1% | 0.06% | +3.5% |
| Q2 2022 | $209,973,000 | +7.9% | 4,994,607 | +0.0% | 0.06% | +29.5% |
| Q1 2022 | $194,550,000 | -2.1% | 4,993,590 | +0.1% | 0.04% | +4.8% |
| Q4 2021 | $198,803,000 | +10.3% | 4,988,792 | +0.0% | 0.04% | +2.4% |
| Q3 2021 | $180,247,000 | -74.0% | 4,987,467 | -70.6% | 0.04% | -74.2% |
| Q2 2021 | $694,482,000 | -3.2% | 16,942,708 | +3.0% | 0.16% | -12.6% |
| Q1 2021 | $717,510,000 | -12.9% | 16,449,101 | -0.0% | 0.18% | -19.1% |
| Q4 2020 | $823,390,000 | +88.7% | 16,451,353 | +58.6% | 0.22% | +66.7% |
| Q3 2020 | $436,436,000 | +10.5% | 10,374,043 | +27.5% | 0.14% | +4.7% |
| Q2 2020 | $395,054,000 | – | 8,137,055 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |